Houston Methodist Sugar Land Hospital
Sugar Land, Texas, United States
General hospital in Sugar Land, Texas
16655 Southwest Fwy, Sugar Land, TX 77479
About Houston Methodist Sugar Land Hospital
Houston Methodist Sugar Land Hospital, located in Sugar Land, Texas, is one of seven community hospitals that are part of Houston Methodist. It employs more than 2,200 people, has an estimated 1,100 affiliated doctors and admits more than 17,000 patients annually.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Houston Methodist Sugar Land Hospital
During the past decade, Houston Methodist Sugar Land Hospital conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 13 clinical trials were completed, i.e. on
average, 52% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 13 clinical trials were completed. i.e. 216.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®
2014-06-01
2023-12-31
Recruiting
126
Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
2015-07-23
2019-02-27
Completed
387
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
2016-07-25
2020-01-29
Completed
509
This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year
2017-09-29
2021-04-07
Terminated
50
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
2017-07-20
2019-02-05
Terminated
119
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months
2017-12-07
2021-03-31
Terminated
264
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
2018-07-13
2019-10-21
Completed
233
A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms
2018-12-04
2023-12-29
Active, not recruiting
128
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Houston Methodist Sugar Land Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 17 trials, followed by "The Methodist Hospital Research Institute" with 4 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "GOG Foundation"
with 3 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Houston Methodist Sugar Land Hospital"
#1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Novartis" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were
collaborators in the rest 17 trials.
Clinical Trials Conditions at Houston Methodist Sugar Land Hospital
According to Clinical.Site data, the most researched conditions in "Houston Methodist Sugar Land Hospital" are
"Ovarian Seromucinous Carcinoma" (6 trials), "Breast Cancer" (5 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (4 trials), "Fallopian Tube Transitional Cell Carcinoma" (4 trials) and "Ovarian Clear Cell Adenocarcinoma" (4 trials). Many other conditions were trialed in "Houston Methodist Sugar Land Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Houston Methodist Sugar Land Hospital
Most popular intervention types in "Houston Methodist Sugar Land Hospital" are "Drug" (32 trials), "Other" (26 trials), "Biological" (15 trials), "Procedure" (13 trials) and "Radiation" (8 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (14 trials), "Laboratory Biomarker Analysis" (12 trials), "Paclitaxel" (12 trials), "Questionnaire Administration" (11 trials) and "Carboplatin" (10 trials). Other intervention names were less common.
Clinical Trials Genders at Houston Methodist Sugar Land Hospital
The vast majority of trials in "Houston Methodist Sugar Land Hospital" are
21 trials for "Female" genders and 20 trials for "All" genders.
Clinical Trials Status at Houston Methodist Sugar Land Hospital
Currently, there are NaN active trials in "Houston Methodist Sugar Land Hospital".
undefined are not yet recruiting,
11 are recruiting,
19 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Houston Methodist Sugar Land Hospital,
1 suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Houston Methodist Sugar Land Hospital, 0 "Phase 1"
clinical trials were conducted, 19 "Phase 2" clinical
trials and 26 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".